Phase II Clinical Trials of New Chemopreventive Agents - Paul Carbone

Abstract

Funding Agency

Agency: National Institute of Health (NIH)
Institute: Division of Cancer Prevention And Control (NCI)
Type: Research and Development Contracts (N01)
Project #: N01CN025434-001001
Application #: 2302099
Study Section

Project Start: 1995-11-20
Project End
Budget Start: 1995-11-20
Budget End: 1999-06-15
Support Year
Fiscal Year: 1996
Total Cost
Indirect Cost

Institution

Name: University of Wisconsin Madison
Department
Type: Schools of Medicine
DUNS #: 161202122

City: Madison
State: WI
Country: United States
Zip Code: 53715

Related projects


NIH 1999 N01 CN	Phase II Clinical Trials of New Chemopreventive Agents Carbone, Paul P. / University of Wisconsin Madison
NIH 1997 N01 CN	Phase II Clinical Trials of New Chemopreventive Agents Carbone, Paul P. / University of Wisconsin Madison
NIH 1996 N01 CN	Phase II Clinical Trials of New Chemopreventive Agents Carbone, Paul P. / University of Wisconsin Madison
NIH 1993 N01 CN	Phase II Clinical Trials of New Chemopreventive Agents Messing, E. / University of Wisconsin Madison

Publications

Messing, Edward; Kim, Kyung Mann; Sharkey, Francis et al. (2006) Randomized prospective phase III trial of difluoromethylornithine vs placebo in preventing recurrence of completely resected low risk superficial bladder cancer. J Urol 176:500-4

Comments

Be the first to comment on Paul Carbone's grant